Table 1 Patient demographic data
From: Efficacy and safety of 5-fluorouracil in infrared monitor guided bleb revision
With 5-FU Needle Revision Group (n = 30) | Without 5-FU Needle Revision Group (n = 13) | P Value | |
|---|---|---|---|
Sex | 0.48* | ||
Men | 15 (51.7%) | 7 (63.6%) | |
Women | 14 (48.3%) | 4 (36.4%) | |
Age at needling (years) | 61.0 ± 16.2 | 63.8 ± 13.5 | 0.68† |
Disease | 0.75* | ||
Primary open-angle glaucoma | 9 (30%) | 5 (38.5%) | |
Secondary glaucoma | 21 (70%) | 8 (61.5%) | |
Neovascular glaucoma | 2 (6.7%) | 0 | |
Exfoliation glaucoma | 6 (20%) | 0 | |
Uveitis | 4 (13.3%) | 4 (30.8%) | |
Others | 9 (30%) | 4 (30.8%) | |
Previous intraocular surgery | 1.4 ± 1.33 | 1.0 ± 1.44 | 0.28† |
Time between previous trabeculectomy and needling (days) | 767.8 ± 898.9 | 890.2 ± 1448.0 | 0.30† |
〜6 months | 14 (46.7%) | 8 (61.5%) | |
6 months 〜 2 years | 5 (16.7%) | 1 (7.7%) | |
2 years 〜 | 11 (36.7%) | 4 (30.8%) | |
IOP pre-needling (mmHg) | 28.9 ± 9.3 | 26.6 ± 9.6 | 0.28† |
Score of glaucoma medications pre-needling (point) | 2.5 ± 2.0 | 2.0 ± 2.1 | 0.38† |